Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02156518 · ClinicalTrials.gov registry record · NA
The Efficacy of Vocal Function Exercises for Laryngeal Cancers
A NA study of Vocal Folds, sponsored by Vrushali Angadi.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 2
- Study locations
NCT02156518: Completed NA study of Vocal Folds, sponsored by Vrushali Angadi.
NCT02156518 is a NA study of Vocal Folds that has completed, run by Vrushali Angadi. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02156518, a NA study of Vocal Folds, has completed, sponsored by Vrushali Angadi.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to determine if the systematic practice of Vocal Function Exercises (VFE) improves selected measures of voice production in participants who have previously been irradiated for early glottic cancers compared to participants who receive the present standard of care, namely, vocal hygiene counseling. It is hypothesized that a prescriptive vocal exercise program (VFE) will improve the voice production of individuals who have been previously treated for laryngeal cancers when compared to participants who receive vocal hygiene alone.
Primary Outcome
Voice Handicap Index, a validated self- assessment tool was used as the primary outcome measure. A score of 0 indicates no handicap, and a score of 120 indicates complete impairment. Data will be presented as pre and post treatment score (pre and post 6 weeks of therapy).
Conditions Studied
Interventions
- PROCEDURE Vocal Function Exercises
- PROCEDURE Vocal Hygiene
Study Locations (2)
Kentucky
- University of Kentucky, Markey Cancer Center - Lexington
- University of Kentucky - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2014-05 |
| Est. Completion | 2018-03 |
| Phase | NA |
What the finished NCT02156518 record still lists
NCT02156518 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Vocal Folds appearing as the primary indexed condition, and to 2 interventions - of which Vocal Function Exercises is the first listed.
NCT02156518 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT02156518 about?
NCT02156518 is a clinical study titled "The Efficacy of Vocal Function Exercises for Laryngeal Cancers". The purpose of this study is to determine if the systematic practice of Vocal Function Exercises (VFE) improves selected measures of voice production in participants who have previously been irradiated for early glottic cancers compared to participants who receive the present standard of care, namel...
What is the current status of trial NCT02156518?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2014-05. Estimated completion is 2018-03.
What conditions does trial NCT02156518 study?
This clinical trial studies the following conditions: Vocal Folds.
What interventions are being tested in trial NCT02156518?
The interventions under investigation include: Vocal Function Exercises (PROCEDURE), Vocal Hygiene (PROCEDURE).
Who is sponsoring clinical trial NCT02156518?
This trial is sponsored by Vrushali Angadi, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02156518 being conducted?
This trial has 2 study locations across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02156518's enrollment target sits among peer trials
12 1913th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia